Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$26.0 - $37.03 $2.08 Million - $2.96 Million
-79,999 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$29.75 - $37.99 $613,593 - $783,543
20,625 Added 34.74%
79,999 $2.56 Million
Q3 2021

Nov 12, 2021

SELL
$29.75 - $37.99 $2.26 Million - $2.89 Million
-76,091 Reduced 56.17%
59,374 $1.87 Million
Q2 2021

Aug 13, 2021

BUY
$27.5 - $38.19 $3.73 Million - $5.17 Million
135,465 New
135,465 $4.96 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $779M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.